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DISCOVERY OF ADULT STEM CELLS
In 1961, Mauro first discovered that skele-
tal muscle fibers of frogs contain mononu-
clear cells underneath the basal lamina
by electron microscope and termed these
“satellite cells” (Mauro, 1961). By contrast,
they failed to find any satellite-like cells
in cardiac muscle after thorough search
of electron micrographs. Since then, satel-
lite cells have been confirmed to be a
true stem cell for skeletal muscle (von
Maltzahn et al., 2013). Adult skeletal mus-
cle possesses extraordinary regeneration
capability (Seale and Rudnicki, 2000).
After exercise or muscle injury, large num-
bers of new muscle fibers are normally
formed within a week because of expan-
sion and differentiation of muscle satel-
lite cells as a stem cell population for
muscle regeneration. In the same year,
Till and McCulloch first established the
concept of stem cells using bone mar-
row transplantation into irradiated mice
(Till and McCulloch, 1961; Armstrong
et al., 2012). They found that donor-
derived hematopoietic stem cells (HSCs)
or progenitor cells can be colonized in
the recipient spleen after transplantation.
A single colony can give rise to multiple
hematopoietic lineages as well as stem or
progenitor cells, indicating the multipo-
tent differentiation and self-renewal abil-
ities for the HSCs or progenitor cells.
In the last two decades, experiments
have established the existence of adult stem
cells in most tissues that appear to have
the ability to differentiate into specific cell
types following injury as a means of regen-
eration in vivo (Barker et al., 2010). For
example, neural stem cells (NSCs) from
the central nervous system can generate
multiple neural cell types to respond (Gage
and Temple, 2013). Bone marrow contains
two distinct stem cell types: marrow stro-
mal cells and HSCs. HSCs possess their
ability to produce all blood cell lineages
(Ugarte and Forsberg, 2013). Multipotent
mesenchymal stem cells derived frommar-
row stromal cells can differentiate into
a wide variety of cell lineages, including
skeletal muscle, neurons, and hematopoi-
etic cells in vitro and following transplan-
tation (Pittenger et al., 1999; Dimarino
et al., 2013). Therefore, many or all tis-
sues may contain a population of stem
cells that can differentiate in an appro-
priate manner in response to the growth
factors and signals provided by their host
tissues. The current challenge is to under-
stand the molecular mechanisms of how
these adult stem cells maintain their stem
cell qualities: specific differentiation capa-
bility, self-renewal activity, and response
to the microenvironments of the stem cell
niche.
DISCOVERY OF EMBRYONIC STEM
CELLS
Embryonic stem cells (ESCs) were first
isolated from the inner cell mass of a
mouse blastocyst, an early-stage embryo,
by Evans and Kaufman (1981). Since then,
ESCs have been of particular interest to
developmental biologists. This is because
ESCs are pluripotent stem cells charac-
terized by their ability to both self-renew
and differentiate into multiple cell lin-
eages, and the differentiation processes of
ESCs can recapitulate embryonic devel-
opment (Bibikova et al., 2008). In addi-
tion, their ability of pluripotency was
utilized to create chimeric mice after
blastocyst injection of ESCs, which allows
us to manipulate gene modifications in
living animals for things such as gen-
erating gene knockout mice and trans-
genic mice (Thomas and Capecchi, 1987).
Following germ line transmission, the
ESCs are able to contribute to whole ani-
mal bodies including germ cells (Capecchi,
1989). Finally, tetraploid embryo com-
plementation experiments, which are the
most stringent tests of full pluripotency,
demonstrate that ESCs are a stem cell line
sufficient for developmental potential to
generate all tissues required for an organ-
ism (Nagy et al., 1990). Because of their
pluripotent differentiation abilities, ESCs
have been considered for clinical use in
regenerative medicine after differentiation
of ESCs into specific cell types such as
liver cells, neurons, cardiomyocytes, and
skeletal muscle (Ben-David et al., 2012).
In 2007, Nobel Laureates (Capecchi and
Evans) made a series of ground-breaking
discoveries concerning ESCs and ESC-
mediated DNA recombination in mice.
The central challenge is to manipulate ES
cells to induce tissue-specific cell types as
well as complex functional organs in vitro,
which is also crucial for cell-based therapy
for regenerative medicine.
DISCOVERY OF CELL FATE
REPROGRAMMING BY
TRANSCRIPTION FACTORS
Our knowledge of the molecular mech-
anisms for stem cell differentiation was
dramatically accelerated since the 1987
discovery of the MyoD-family of tran-
scription factors, termed the myogenic
regulatory factors (MRFs), by Weintraub
group (Davis et al., 1987). TheMRFs com-
prise a group of muscle-specific basic
helix-loop-helix transcription factors,
consisting of MyoD, Myf5, myogenin,
www.frontiersin.org February 2014 | Volume 2 | Article 2 | 1
CELL AND DEVELOPMENTAL BIOLOGY
Asakura Grand challenges in stem cell
and MRF4. The MRFs can initiate tran-
scription of muscle-specific genes through
direct binding to E-boxes, a consensus
DNA motif, existing in the regulatory
regions of these genes (Weintraub et al.,
1991). Expression of a single MRF gene,
MyoD, in various cell types, includ-
ing fibroblasts, pigment, nerve, fat and
liver cells, is able to initiate myogenic
reprogramming (Weintraub et al., 1989).
Therefore, the MyoD family is the first dis-
covered master reprogramming factor.
Thereafter, many scientists have suc-
cessfully identified tissue-specific and
pluripotent master reprogramming factors
whose involvement includes neurogenesis
and ES cells.
In 2006, Takahashi and Yamanaka
first discovered that expression of the
four transcription factors (Yamanaka
factors), Oct4, Sox2, cMyc, and Klf4
generate induced pluripotent stem cells
(iPSCs) from fibroblasts (Takahashi and
Yamanaka, 2006). Currently, many types
of somatic cells including B lymphocytes,
natural killer T cells, stomach cells, liver
cells, pancreatic β-cells, NSCs and skele-
tal myoblasts can be reprogrammed into
iPSCs by expression of Yamanaka factors
(Kim et al., 2010; Watanabe et al., 2011;
Kumar et al., 2013). The iPSCs generated
from adult tissues have been thought to
mimic ESCs. Therefore, these Yamanaka
factors are considered as pluripotent
reprogramming factors. In addition, iPSCs
hold tremendous therapeutic promise due
to their ability to proliferate, differentiate,
and self-renew. The quick generation of
iPSCs from any somatic cells enables them
to be a source of patient-derived cells for
regenerative therapies after differentiation
into particular cell types (Yoshida and
Yamanaka, 2010). In 2012, Yamanaka and
Gurdon were awarded the Nobel Prize for
Physiology or Medicine for the discov-
ery of generation of iPSCs and nuclear
reprogramming; in both of which, mature
somatic cells can be converted to pluripo-
tent stem cells (Gurdon, 1962; Takahashi
and Yamanaka, 2006; Yamanaka and Blau,
2010). However, there are several safety
concerns such as the potential risk of
tumorigenesis and the genetic and epi-
genetic aberrations after transplantation
of iPSC-derived cells, partly diminishing
the enthusiasm of using iPSC technol-
ogy for mediated regenerative medicine
in humans (Barrilleaux and Knoepfler,
2011). Direct reprogramming can over-
come these difficulties since somatic
cells can be directly reprogrammed
into particular cell types without going
through the iPSC or pluripotent stage.
As mentioned above, MyoD is the first
reprogramming factor for myogene-
sis. In the last few years, several papers
reported the direct-reprogramming of
fibroblasts into differentiated cell lin-
eages including neurons, cardiomyocytes,
hepatocytes, pancreatic β-cells, and
blood cell progenitors by transduction
of specific transcription factor cocktails
(Chambers and Studer, 2011). Directed
reprogramming technology will allow
us to understand the molecular mech-
anisms of stem cell differentiation and
de-differentiation as well as provide use-
ful and safe cell sources for therapies of
many regenerative medicines in humans
(Morris and Daley, 2013). The generation
of efficient, functional, tissue-specific cell
types from iPSCs and other somatic cells
remains a challenge.
The goal of Stem Cell Research is to
publish all aspects of stem cell research
ranging from molecular and cellular
biology to developmental biology and
tissue regeneration. In addition, the jour-
nal will consider papers in areas of the
field in progenitor or stem cells related
to cloning, pluripotency, reprogram-
ming, proteomics, genetics, epigenetics,
genomics, non-coding RNAs, and cancer
stem cells. Our aim is to foster research
that integrates all levels of stem cell biol-
ogy, including developmental biology,
tissue growth and regeneration, diseases,
aging, and cancer. We welcome original
papers on a broad range of subjects relat-
ing to stem cells, developmental biology,
tissue regeneration, disease models, drug
screening, and bioinformatics, related to
stem cell biology and tissue regeneration.
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